Original language | English (US) |
---|---|
Pages (from-to) | 518-519 |
Number of pages | 2 |
Journal | CA Cancer Journal for Clinicians |
Volume | 70 |
Issue number | 6 |
DOIs | |
State | Published - Nov 1 2020 |
ASJC Scopus subject areas
- Hematology
- Oncology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: CA Cancer Journal for Clinicians, Vol. 70, No. 6, 01.11.2020, p. 518-519.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - The case for catch-up human papillomavirus vaccination in at-risk populations
T2 - Rural communities and survivors of pediatric and young adult cancers
AU - Kacew, Alec J.
AU - Grimes, Allison C.
AU - Roth, Michael
AU - Teoh, Deanna
AU - Landier, Wendy
AU - Strohbehn, Garth W.
AU - Paskett, Electra D.
N1 - Funding Information: Alec J. Kacew has received research support from the Pritzker School of Medicine and the American Society of Hematology for work performed outside of the current study. Allison C. Grimes has received grants from the Cancer Prevention Research Institute of Texas for work performed outside of the current study. Deanna Teoh has received grants from Acelity and salary support for her role as a local principal investigator for an industry‐sponsored trial from GlaxoSmithKline for work performed outside of the current study. Wendy Landier has received grants from the National Cancer Institute of the National Institutes of Health and nonfinancial support to her institution from Merck, Sharp & Dohme for work performed outside of the current study. Garth W. Strohbehn's institution has received fellowship funding support from Abbott Laboratories Inc and he holds a filed provisional patent not applicable to the current study. Electra D. Paskett has received grants from the National Cancer Institute of the National Institutes of Health for work performed as part of the current study and has received grants from the Merck Foundation, Pfizer, the Breast Cancer Research Foundation, Foxconn, and the One Family Foundation for work performed outside of the current study. Michael Roth made no disclosures.
PY - 2020/11/1
Y1 - 2020/11/1
UR - http://www.scopus.com/inward/record.url?scp=85092572515&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092572515&partnerID=8YFLogxK
U2 - 10.3322/caac.21649
DO - 10.3322/caac.21649
M3 - Letter
C2 - 33063840
AN - SCOPUS:85092572515
SN - 0007-9235
VL - 70
SP - 518
EP - 519
JO - CA Cancer Journal for Clinicians
JF - CA Cancer Journal for Clinicians
IS - 6
ER -